The prevalence of the BRCA2 K3326* variant in our sample, along with the evidence of an association with lung, aero digestive, and pancreatic cancer [26–28] indicated that this variant may be of minimal risk when inherited alone, but may act as a modifier of penetrance to a secondary more deleterious mutation. Here, BRCA2 is linked to familial pancreatic carcinoma.